PEOPLE - Changes at DiagnoCure:
This article was originally published in Clinica
Executive Summary
Camille Chypre, vice-president of R&D, will be leaving Canadian cancer test developer DiagnoCure. Until a replacement for Dr Chypre is appointed, Dr Yves Fradet, senior vice-president and chief scientific officer, Lyson Piche, director of R&D, will temporarily take on his duties. Pierre Desy, president and CEO, stressed that Dr Chypre's departure would "not impact the timing of any current development projects" at the Quebec City, Quebec-based company.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.